BioCentury
ARTICLE | Management Tracks

CMO Noonberg enters Maze; plus Neogene, Expansion, Nkarta, Supernus and Myriad 

October 7, 2020 12:34 AM UTC

Genetic modifier company Maze Therapeutics has hired Sarah Noonberg as CMO. Noonberg was CMO of Nohla Therapeutics Inc. Maze debuted in February 2019 with a $191 million venture round led by Third Rock Ventures and Arch Venture Partners.

After raising a $110 million series A round last month, cell therapy developer  Neogene Therapeutics Inc. has named Franz Humer as executive chairman. Humer was chairman and CEO of Roche (SIX:ROG; OTCQX:RHHBY) before retiring in 2014. ...